Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy

被引:0
|
作者
Li Zhuo
Nianrong Zhang
Guming Zou
Dapeng Chen
Wenge Li
机构
[1] China–Japan Friendship Hospital,Department of Nephrology
来源
Frontiers of Medicine | 2017年 / 11卷
关键词
diabetic nephropathy; clinical characteristics; renal biopsy; outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
Kidney damage is common in patients with diabetes mellitus (DM). However, whether the type of kidney damage can be reliably diagnosed using clinical data alone remains unclear. Predictive factors for diabetic nephropathy (DN) outcomes are also poorly understood. In this study, the clinical manifestations of 111 cases of biopsy-proven DN were described, and the clinical and pathological parameters of patients with different DN outcomes were compared. Results showed that long DM duration ( > 10 years in 32.4% of patients), severe proteinuria (62.2%), and renal dysfunction (estimated glomerular filtration rate [eGFR] < 60 mL/(min$1.73 m2)) (52.3%) did not accurately indicate whether the condition of these patients progressed to DN. Hematuria (48.6%) failed to specify either DN or nondiabetic renal disease. Diabetic retinopathy (78.4%) was a crucial complication in patients with DN. Kaplan–Meier analysis revealed that the renal survival of 53 patients who were diagnosed with DN and were followed up was not significantly associated with glomerular classification (P > 0.05). Cox’s regression analysis demonstrated that renal survival time was significantly influenced by sex (β = 1.394, P = 0.038), hematuria (β = 0.036, P = 0.029), and eGFR (β =–0.039, P = 0.002) but was not significantly affected by age, 24 h urinary protein excretion, or glomerular classification (P > 0.05). In conclusion, the clinical characteristics of DN vary, and renal biopsy is necessary to determine renal damage patterns. Sex, hematuria, and the eGFR may affect DN outcomes, whereas the glomerular classification may not.
引用
收藏
页码:386 / 392
页数:6
相关论文
共 50 条
  • [21] The spectrum of biopsy-proven kidney diseases in elderly Chinese patients
    Jin, Bo
    Zeng, Caihong
    Ge, Yongchun
    Le, Weibo
    Xie, Honglang
    Chen, Hao
    Liang, Shaoshan
    Xu, Feng
    Jiang, Song
    Liu, Zhihong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (12) : 2251 - 2259
  • [22] Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy
    Wu, Chung-Ze
    Chang, Li-Chien
    Lin, Yuh-Feng
    Hung, Yi-Jen
    Pei, Dee
    Chu, Nain-Feng
    Chen, Jin-Shuen
    CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1324 - 1329
  • [23] Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy
    Miho Shimizu
    Kengo Furuichi
    Shinji Kitajima
    Tadashi Toyama
    Megumi Oshima
    Hisayuki Ogura
    Koichi Sato
    Shiori Nakagawa
    Yuta Yamamura
    Taro Miyagawa
    Akinori Hara
    Yasunori Iwata
    Norihiko Sakai
    Kiyoki Kitagawa
    Mitsuhiro Yoshimura
    Hitoshi Yokoyama
    Takashi Wada
    BMC Nephrology, 22
  • [24] Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy
    Shimizu, Miho
    Furuichi, Kengo
    Kitajima, Shinji
    Toyama, Tadashi
    Oshima, Megumi
    Ogura, Hisayuki
    Sato, Koichi
    Nakagawa, Shiori
    Yamamura, Yuta
    Miyagawa, Taro
    Hara, Akinori
    Iwata, Yasunori
    Sakai, Norihiko
    Kitagawa, Kiyoki
    Yoshimura, Mitsuhiro
    Yokoyama, Hitoshi
    Wada, Takashi
    BMC NEPHROLOGY, 2021, 22 (01)
  • [25] The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes A nested case control study
    Shang, Jin
    Yu, Dahai
    Cai, Yamei
    Wang, Zheng
    Zhao, Bin
    Zhao, Zhanzheng
    Simmons, David
    MEDICINE, 2019, 98 (46) : e17995
  • [26] Biopsy-proven kidney diseases in the elderly: clinical characteristics, renal histopathological spectrum and prognostic factors
    Chen, Yue
    Li, Ping
    Cui, Chunli
    Yuan, Aihong
    Zhang, Kun
    Yu, Chen
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2016, 44 (05) : 1092 - 1102
  • [27] A nationwide cross-sectional analysis of biopsy-proven Fabry nephropathy: the Japan Renal Biopsy Registry
    Nasu, Makoto
    Nakagawa, Naoki
    Hara, Shigeo
    Yano, Junko
    Kurokawa, Yuka
    Nakamura, Nao
    Yokoyama, Hitoshi
    Shimizu, Akira
    Sugiyama, Hitoshi
    Sato, Hiroshi
    Fukami, Kei
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (02) : 141 - 150
  • [28] A nationwide cross-sectional analysis of biopsy-proven Fabry nephropathy: the Japan Renal Biopsy Registry
    Makoto Nasu
    Naoki Nakagawa
    Shigeo Hara
    Junko Yano
    Yuka Kurokawa
    Nao Nakamura
    Hitoshi Yokoyama
    Akira Shimizu
    Hitoshi Sugiyama
    Hiroshi Sato
    Kei Fukami
    Clinical and Experimental Nephrology, 2023, 27 : 141 - 150
  • [29] The incidence of biopsy-proven glomerulonephritis in Australia
    Briganti, EM
    Dowling, J
    Finlay, M
    Hill, PA
    Jones, CL
    Kincaid-Smith, PS
    Sinclair, R
    McNeil, JJ
    Atkins, RC
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) : 1364 - 1367
  • [30] Temporal Trends in the Epidemiology of Biopsy-Proven Glomerular Diseases: An Alarming Increase in Diabetic Glomerulosclerosis
    Hou, Jean
    Haas, Mark
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (04): : 556 - 558